117 related articles for article (PubMed ID: 27570115)
1. Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma.
Xie JW; Sun YQ; Feng CY; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Yang YH; Huang CM
Eur J Surg Oncol; 2016 Oct; 42(10):1464-70. PubMed ID: 27570115
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
4. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma.
Xu B; Chu Y; Hu Q; Song Q
Technol Cancer Res Treat; 2021; 20():15330338211055340. PubMed ID: 34806493
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic analysis of 42 patients with gastric neuroendocrine carcinoma].
Kou Y; Gao YB; Ma J; Yang K; Fu Q; Xie JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):570-3. PubMed ID: 23801213
[TBL] [Abstract][Full Text] [Related]
6. Different long-term oncologic outcomes after radical surgical resection for neuroendocrine carcinoma and adenocarcinoma of the stomach.
Xie JW; Lu J; Lin JX; Zheng CH; Li P; Wang JB; Chen QY; Cao LL; Lin M; Tu RH; Huang CM
Oncotarget; 2017 Aug; 8(34):57495-57504. PubMed ID: 28915689
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and Prognostic Analysis of Neuroendocrine Carcinoma of the Colorectum.
Zhang Y; Xie J; Wang J; Yang D; Jiang Z; Han G; Fu Q; Zhang Y
Adv Clin Exp Med; 2016; 25(4):719-24. PubMed ID: 27629846
[TBL] [Abstract][Full Text] [Related]
8. [Gastric neuroendocrine carcinoma and gastric carcinoma with neuroendocrine cell differentiation: a clinical and prognostic analysis].
Wang HF; Wu AW; Yuan P; Liu YQ; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Feb; 14(2):96-9. PubMed ID: 21365498
[TBL] [Abstract][Full Text] [Related]
9. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of malignancy using Ki-67 labeling index for gastric stromal tumor.
Nagasako Y; Misawa K; Kohashi S; Hasegawa K; Okawa Y; Sano H; Takada A; Sato H
Gastric Cancer; 2003; 6(3):168-72. PubMed ID: 14520530
[TBL] [Abstract][Full Text] [Related]
11. Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses.
Kim BS; Oh ST; Yook JH; Kim KC; Kim MG; Jeong JW; Kim BS
Am J Surg; 2010 Sep; 200(3):328-33. PubMed ID: 20385369
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and genetic characteristics of gastric neuroendocrine tumour (NET) G3 and comparisons with neuroendocrine carcinoma and NET G2.
Chen S; Sun L; Chen H; Li J; Lu C; Yang Y; Sun Y
Histopathology; 2023 Nov; 83(5):700-711. PubMed ID: 37403531
[TBL] [Abstract][Full Text] [Related]
13. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
Özaslan E; Demir S; Karaca H; Güven K
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
[TBL] [Abstract][Full Text] [Related]
15. Modified AJCC staging of gastric neuroendocrine carcinoma based on T staging can improve the capacity of prognosis assessment.
Xie JW; Li P; Wang JB; Lin JX; Lu J; Chen QY; Yang YH; Kang DY; Zheng CH; Huang CM
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2391-2397. PubMed ID: 30209612
[TBL] [Abstract][Full Text] [Related]
16. [Long-term outcome and analysis of prognostic factors in 114 cases of postoperative stage III gastric cancer].
Zhang Y; Ma LW
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):863-6. PubMed ID: 24447487
[TBL] [Abstract][Full Text] [Related]
17. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
18. [The diagnosis, treatment and prognosis evaluation of gastric small cell carcinoma: analysis of 41 cases].
Huang S; Zheng ZX; Xu Q; Yuan XH
Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):225-9. PubMed ID: 23859323
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features and differences of p53 and Ki-67 expression in adenosquamous and squamous cell carcinomas of the stomach].
Kim YS; Heo WS; Chae KH; Gang YS; Jung JH; Kim SH; Seong JK; Lee BS; Jeong HY; Song KS; Shin KS; Cho JS; Noh SM
Korean J Gastroenterol; 2006 Jun; 47(6):425-31. PubMed ID: 16809949
[TBL] [Abstract][Full Text] [Related]
20. [Surgical treatment and survival analysis of recurrent carcinoma within gastric remnant:a report of 60 cases].
Du YA; Guo JM; Zhang YL; Zhou LX; Zhang ZW; Wang XB; Hu JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jul; 8(4):331-3. PubMed ID: 16167255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
